Search

everythinglearnresearchcommunity

for

Search:↓

A 12-year-old boy with PAIS successfully developed male characteristics using high-dose testosterone and anastrozole.

A man experienced hair loss from radiotherapy, which can be temporary or permanent depending on radiation dose, with potential treatments available.

Tattooing helps treat skin conditions, reconstruct nipple-areola, mark radiation fields, and locate lesions.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Radiotherapy can cause rare changes in hair color, which should be discussed with patients.

X-ray exposure affects developing hair follicles.

Insulin resistance is linked to larger thyroid volume in patients with polycystic ovary syndrome.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Scientists found new nonsteroidal compounds that can act like natural male hormones and might help treat male fertility and hormone issues.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

LRIG1 protein affects hair growth by regulating skin receptors, leading to hair loss when overexpressed.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Thyroid hormone receptor β1 is found in human hair follicles and helps them survive.

Spironolactone reduces the number of androgen receptor sites in rat skin by blocking them with its metabolite.

A new method quickly detects hair changes from EGFR inhibitors using a microscope.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

The patient had a severe allergic reaction to gold treatment.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Androgen receptor activity is influenced by hormones, co-factors, modifications, and mutations.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Levothyroxine treatment fully cured the young man's hypothyroid symptoms.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.